5.63
Precedente Chiudi:
$5.88
Aprire:
$5.67
Volume 24 ore:
1.47M
Relative Volume:
1.18
Capitalizzazione di mercato:
$305.58M
Reddito:
$1.02B
Utile/perdita netta:
$-757.20M
Rapporto P/E:
-0.3814
EPS:
-14.76
Flusso di cassa netto:
$-257.90M
1 W Prestazione:
-21.48%
1M Prestazione:
-14.70%
6M Prestazione:
-49.96%
1 anno Prestazione:
-46.74%
Emergent Biosolutions Inc Stock (EBS) Company Profile
Nome
Emergent Biosolutions Inc
Settore
Telefono
240-631-3200
Indirizzo
300 PROFESSIONAL DR, GAITHERSBURG, MD
Confronta EBS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
EBS
Emergent Biosolutions Inc
|
5.63 | 319.15M | 1.02B | -757.20M | -257.90M | -14.76 |
![]()
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
![]()
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-30 | Iniziato | H.C. Wainwright | Buy |
2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
2024-03-07 | Aggiornamento | The Benchmark Company | Hold → Buy |
2023-11-20 | Ripresa | JP Morgan | Underweight |
2023-08-29 | Downgrade | The Benchmark Company | Buy → Hold |
2023-04-10 | Aggiornamento | The Benchmark Company | Hold → Buy |
2023-03-17 | Downgrade | JP Morgan | Neutral → Underweight |
2022-11-10 | Downgrade | The Benchmark Company | Buy → Hold |
2022-04-29 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
2022-01-20 | Aggiornamento | The Benchmark Company | Hold → Buy |
2021-11-08 | Downgrade | The Benchmark Company | Buy → Hold |
2021-05-05 | Downgrade | Argus | Buy → Hold |
2021-04-07 | Iniziato | The Benchmark Company | Buy |
2021-02-24 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
2021-02-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2020-09-14 | Ripresa | JP Morgan | Neutral |
2020-07-31 | Reiterato | Chardan Capital Markets | Buy |
2019-09-12 | Iniziato | Guggenheim | Buy |
2019-09-04 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
2018-11-02 | Aggiornamento | Goldman | Neutral → Buy |
2018-08-03 | Reiterato | Chardan Capital Markets | Buy |
2018-06-13 | Iniziato | Argus | Buy |
2018-04-25 | Downgrade | Wells Fargo | Outperform → Market Perform |
2018-01-24 | Iniziato | Goldman | Neutral |
2018-01-16 | Reiterato | Chardan Capital Markets | Buy |
2016-06-28 | Reiterato | Singular Research | Buy |
2016-04-15 | Iniziato | Chardan Capital Markets | Buy |
2016-03-28 | Iniziato | Singular Research | Buy |
2016-02-19 | Iniziato | Wells Fargo | Outperform |
2014-05-15 | Iniziato | Summer Street Research | Buy |
2011-05-31 | Reiterato | WBB Securities | Strong Buy |
2011-01-10 | Reiterato | Wedbush | Outperform |
2010-11-05 | Reiterato | Wedbush | Outperform |
2010-08-18 | Aggiornamento | WBB Securities | Buy → Strong Buy |
2010-08-06 | Reiterato | Caris & Company | Buy |
Mostra tutto
Emergent Biosolutions Inc Borsa (EBS) Ultime notizie
Insider Sellers Might Regret Selling Emergent BioSolutions Shares at a Lower Price Than Current Market Value - simplywall.st
What catalysts could drive Emergent BioSolutions Inc. stock higher in 2025Chart Pattern Ideas For Fast Growth - jammulinksnews.com
What institutional investors are buying Emergent BioSolutions Inc. stockPost Market Outlook For Every Investor - jammulinksnews.com
Why Emergent BioSolutions Inc. stock attracts strong analyst attentionValue Investing Picks With Stability Outlined - beatles.ru
Emergent BioSolutions Inc. Recovery Hinges on Volume BreakoutPotential Breakout Stock List Published This Week - metal.it
Investors Hope for Bounce in Emergent BioSolutions Inc. After SelloffAI Based High Gain Watchlist Scanner Shared - metal.it
Can Emergent BioSolutions Inc. Regain Momentum After BreakdownCapital Growth With Controlled Risk Picks Suggested - metal.it
Published on: 2025-07-29 03:10:46 - metal.it
Emergent BioSolutions (EBS) Applauds Naloxone Accessibility in U - GuruFocus
Emergent Applauds Availability of Over-the-Counter Naloxone in U.S. House of Representatives - The Manila Times
Emergent BioSolutions Publishes Review on Brincidofovir for Mpox Treatment in Expert Review of Anti-infective Therapy - Quiver Quantitative
Is Emergent BioSolutions Inc. stock overvalued or undervaluedHigh-performance stocks for savvy investors - jammulinksnews.com
U.S. House Takes Historic Step: NARCAN Now Available in Every Building to Prevent Opioid Deaths - Stock Titan
What are analysts’ price targets for Emergent BioSolutions Inc. in the next 12 monthsFree Stock Selection - jammulinksnews.com
How many analysts rate Emergent BioSolutions Inc. as a “Buy”Invest smarter with advanced market data - jammulinksnews.com
Published on: 2025-07-28 04:58:37 - jammulinksnews.com
How volatile is Emergent BioSolutions Inc. stock compared to the marketRecord-breaking gains - jammulinksnews.com
Is it the right time to buy Emergent BioSolutions Inc. stockInvest confidently with actionable market data - jammulinksnews.com
How strong is Emergent BioSolutions Inc. company’s balance sheetMaximize returns with strategic stock selection - jammulinksnews.com
What drives Emergent BioSolutions Inc. stock priceTriple-digit profit margins - PrintWeekIndia
What analysts say about Emergent BioSolutions Inc. stockExponential wealth increase - PrintWeekIndia
Is Emergent BioSolutions Inc. a good long term investmentHigh-yield growth strategies - PrintWeekIndia
Emergent BioSolutions Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com
Is MDU Resources Group Inc. a good long term investmentHigh-yield investments - jammulinksnews.com
AGYS Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
Hawthorn Bancshares Inc. Stock Analysis and ForecastBreakthrough capital growth - jammulinksnews.com
Emergent Biosolutions Inc Azioni (EBS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):